xanthenes has been researched along with Acute Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, I; Amhaoul, H; Boets, S; Dedeurwaerdere, S; Janssens, P; Langlois, X; Van Eetveldt, A | 1 |
| Enright, LE; Murphy, TH; Zhang, S | 1 |
| Ban, TA; Jarrold, L; Sterlin, C | 1 |
| Balandina, EK; Smirnov, VV; Stefani, DV | 1 |
| Ban, TA; Lehmann, HE; Oliveros, RT; Saxena, BM; Sterlin, C | 1 |
| Kingstone, E; Kolivakis, T; Kossatz, I | 1 |
| Rudobielski, R | 1 |
| Barboráková, E; Mrna, B; Ríkovský, S; Zapletálek, M | 1 |
3 trial(s) available for xanthenes and Acute Disease
| Article | Year |
|---|---|
The place of thiothixene among the thioxanthenes.
Topics: Acute Disease; Adolescent; Adult; Central Nervous System; Chlorprothixene; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thiothixene; Tranquilizing Agents; Xanthenes | 1972 |
Thiothixene. Its range of therapeutic activity.
Topics: Acute Disease; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Female; Humans; Male; Middle Aged; Neurotic Disorders; Psychiatric Status Rating Scales; Schizophrenia; Thiothixene; Xanthenes | 1970 |
Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics.
Topics: Acute Disease; Adolescent; Adult; Aged; Aspartate Aminotransferases; Blood Pressure; Body Weight; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Liver Function Tests; Male; Middle Aged; Parkinson Disease, Secondary; Perphenazine; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Vision Disorders; Xanthenes; Xerostomia | 1970 |
5 other study(ies) available for xanthenes and Acute Disease
| Article | Year |
|---|---|
Metabotropic glutamate receptor 2/3 density and its relation to the hippocampal neuropathology in a model of temporal lobe epilepsy in rats.
Topics: Acute Disease; Amino Acids; Animals; Autoradiography; Chronic Disease; Cross-Sectional Studies; Disease Models, Animal; Disease Progression; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; Hippocampus; Kainic Acid; Male; Parietal Lobe; Radiopharmaceuticals; Rats, Wistar; Receptors, Metabotropic Glutamate; Thalamus; Time Factors; Tritium; Xanthenes | 2016 |
Fine mapping of the spatial relationship between acute ischemia and dendritic structure indicates selective vulnerability of layer V neuron dendritic tufts within single neurons in vivo.
Topics: Acute Disease; Animals; Brain Ischemia; Brain Mapping; Cerebrovascular Circulation; Dendrites; Fluorescent Dyes; Luminescent Proteins; Mice; Mice, Transgenic; Neurons; Regional Blood Flow; Stroke; Xanthenes | 2007 |
[Obtaining luminescent monospecific sera against human immunoglobulins (G, A and M)].
Topics: Acute Disease; Benzoates; Chromatography, Gel; Chronic Disease; Coloring Agents; Fluoresceins; Humans; Immune Sera; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Leukemia; Luminescent Measurements; Pyelonephritis; Quaternary Ammonium Compounds; Thiocyanates; Ultracentrifugation; Xanthenes | 1973 |
[Anti-amine therapy in acute iritis].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Amines; Child; Evaluation Studies as Topic; Female; Humans; Injections, Intramuscular; Iritis; Male; Middle Aged; Piperidines; Xanthenes | 1972 |
[Clinical experience with flupenthixol].
Topics: Acute Disease; Chronic Disease; Humans; Paranoid Disorders; Schizophrenia; Xanthenes | 1967 |